VeriMom¿Debo evitar retinoyl pentapeptide-4 durante el embarazo? | VeriMom
No evidence in EU Cosmetics Annex II/III or harmonised CLP of reproductive hazards for palmitoyl pentapeptide‑4; regulatory/industry sources and ingredient databases list it as a signal peptide (Matrixyl) with no reproductive or teratogenic classification. Topical peptides have low but measurable dermal absorption, and palmitoyl conjugation increases lipophilicity and skin penetration modestly, so exposure is low but measurable in adults. Sources: EWG ingredient page; ingredient summaries (Paula's Choice) and peptide safety overview (CIR pentapeptides review).
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- ¿Es retinoyl pentapeptide-4 seguro durante el embarazo?
- No evidence in EU Cosmetics Annex II/III or harmonised CLP of reproductive hazards for palmitoyl pentapeptide‑4; regulatory/industry sources and ingredient databases list it as a signal peptide (Matrixyl) with no reproductive or teratogenic classification. Topical peptides have low but measurable dermal absorption, and palmitoyl conjugation increases lipophilicity and skin penetration modestly, so exposure is low but measurable in adults. Sources: EWG ingredient page; ingredient summaries (Paula's Choice) and peptide safety overview (CIR pentapeptides review).
- ¿Es retinoyl pentapeptide-4 seguro durante la lactancia?
- Same rationale as pregnancy: no CMR or reproductive classifications and no published animal/human developmental or lactation toxicity for palmitoyl pentapeptide‑4. Topical exposure to parent peptide is low but measurable; transfer into breastmilk not reported. Evidence absence supports low hazard. (See same sources.)
- ¿Es retinoyl pentapeptide-4 seguro para la piel del bebé?
- No infant‑specific developmental or toxicity data were found. Because infant/young‑child skin has higher absorption (higher surface‑area:weight and immature barrier), increase exposure score by +1 over adult (adult e=1 → infant e=2). No data indicate increased hazard or specific mechanisms affecting development or endocrine systems for this peptide. Sources: peptide safety reviews and product/INCI descriptions.
- ¿Cómo puntúa VeriMom a retinoyl pentapeptide-4?
- VeriMom puntúa retinoyl pentapeptide-4 en 13/100 (riesgo alto) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a retinoyl pentapeptide-4 en el embarazo?
- Consulta nuestra lista de alternativas seguras a retinoyl pentapeptide-4 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.